FDA OKs J&J’s Tecnis PureSee Lens for Cataract Surgery

FDA has approved Johnson & Johnson’s Tecnis PureSee Intraocular Lens, a new extended depth-of-focus lens for use in cataract surgery, giving surgeons a new option designed to improve visual range while maintaining strong visual quality.

According to Johnson & Johnson, the lens is the first FDA-approved “extended depth-of-focus” intraocular lens in the U.S. that maintains contrast sensitivity comparable to a traditional aspheric monofocal IOL, which are widely considered the benchmark for visual clarity.

Clinical data submitted to regulators showed high levels of patient satisfaction. In studies cited by the company, 97% of patients reported no very bothersome visual disturbances, such as glare or halos, and 97% said they would recommend the lens to friends or family, the company says. The lens is designed to provide strong distance and intermediate vision with some near vision capability, which may reduce the need for glasses after surgery.